MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
© 1990 Nature Publishing Group
Suggest Documents
Human gene therapy: anticancer trial's surprise approval.
Stem-cell gene therapy moves toward approval.
Gene therapy for cancer: regulatory considerations for approval.
Gene therapy for ADA takes next step.
What Is Next for Retinal Gene Therapy?
NIH gene patents, round two.
Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.
Round-headed human spermatozoa.
Gene therapy in the clinics: shifting into the next gear.
US company's gene therapy trial is first to bypass RAC for approval.
Endovascular Therapy: The Second Round Begins.
Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancer.
Human gene therapy and congress.
FDA declines approval of testosterone drug for third time.
Fetal therapy: the next generation.
Maintenance fluid therapy: what's next.
Interspecific gene transfer: where next?
FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.
Gene therapy in epilepsy-is it time for clinical trials?
New human gene therapy institute in Pennsylvania.
Human gene therapy. First experiment approved.
Human gene therapy comes of age.
Legal regulation of human gene therapy.
TIL human gene therapy clinical protocol.
Human gene therapy. Approval next time round?
© 1990 Nature Publishing Group...
144KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Human gene therapy: anticancer trial's surprise approval.
Stem-cell gene therapy moves toward approval.
Gene therapy for cancer: regulatory considerations for approval.
Gene therapy for ADA takes next step.
What Is Next for Retinal Gene Therapy?
NIH gene patents, round two.
Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.
Round-headed human spermatozoa.
Gene therapy in the clinics: shifting into the next gear.
US company's gene therapy trial is first to bypass RAC for approval.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms